Membrane-Anchored Serine Proteases in Vertebrate Cell and Developmental Biology()

Por Szabo, Roman, Bugge, Thomas H.
Publicado em 2011

Imaging collagen degradation in vivo highlights a key role for M2-polarized macrophages in extracellular matrix degradation

Por Madsen, Daniel H, Bugge, Thomas H
Publicado em 2013

The source of matrix-degrading enzymes in human cancer: Problems of research reproducibility and possible solutions

Por Madsen, Daniel H., Bugge, Thomas H.
Publicado no J Cell Biol (2015)

Plasminogen-receptor (KT) : Plasminogen activation and beyond

Por Flick, Matthew J., Bugge, Thomas H.
Publicado no J Thromb Haemost (2016)

Matriptase: Potent Proteolysis on the Cell Surface

Por List, Karin, Bugge, Thomas H, Szabo, Roman
Publicado em 2006

Type II Transmembrane Serine Proteases

Por Bugge, Thomas H., Antalis, Toni M., Wu, Qingyu
Publicado em 2009

Membrane-Anchored Serine Proteases in Health and Disease

Por Antalis, Toni M., Bugge, Thomas H., Wu, Qingyu
Publicado em 2011

Distinct Developmental Functions of Prostasin (CAP1/PRSS8) Zymogen and Activated Prostasin

Por Friis, Stine, Madsen, Daniel H., Bugge, Thomas H.
Publicado no J Biol Chem (2016)

Loss of Matriptase Suppression Underlies Spint1 Mutation-Associated Ichthyosis and Postnatal Lethality

Por Szabo, Roman, Kosa, Peter, List, Karin, Bugge, Thomas H.
Publicado em 2009

Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis

Por Kosa, Peter, Szabo, Roman, Molinolo, Alfredo A., Bugge, Thomas H.
Publicado em 2011

Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin

Por Szabo, Roman, Lantsman, Taliya, Peters, Diane E., Bugge, Thomas H.
Publicado no Development (2016)

Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin

Por Tsirka, Stella E., Bugge, Thomas H., Degen, Jay L., Strickland, Sidney
Publicado em 1997

Imaging Specific Cell Surface Protease Activity in Living Cells Using Reengineered Bacterial Cytotoxins

Por Hobson, John P., Liu, Shihui, Leppla, Stephen H., Bugge, Thomas H.
Publicado em 2009

Dissecting the Urokinase Activation Pathway Using Urokinase-Activated Anthrax Toxin

Por Liu, Shihui, Bugge, Thomas H., Frankel, Arthur E., Leppla, Stephen H.
Publicado em 2009

TMPRSS13 deficiency impairs stratum corneum formation and epidermal barrier acquisition

Por Madsen, Daniel H., Szabo, Roman, Molinolo, Alfredo A., Bugge, Thomas H.
Publicado no Biochem J (2014)

Delineation of Matriptase Protein Expression by Enzymatic Gene Trapping Suggests Diverging Roles in Barrier Function, Hair Formation, and Squamous Cell Carcinogenesis

Por List, Karin, Szabo, Roman, Molinolo, Alfredo, Nielsen, Boye Schnack, Bugge, Thomas H.
Publicado em 2006

Accelerated Wound Healing by mTOR Activation in Genetically Defined Mouse Models

Por Squarize, Cristiane H., Castilho, Rogerio M., Bugge, Thomas H., Gutkind, J. Silvio
Publicado em 2010

Regulation of Feto-Maternal Barrier by Matriptase- and PAR-2-Mediated Signaling Is Required for Placental Morphogenesis and Mouse Embryonic Survival

Por Szabo, Roman, Peters, Diane E., Kosa, Peter, Camerer, Eric, Bugge, Thomas H.
Publicado em 2014

Potent antitumor activity of a urokinase-activated engineered anthrax toxin

Por Liu, Shihui, Aaronson, Hannah, Mitola, David J., Leppla, Stephen H., Bugge, Thomas H.
Publicado em 2003

Matriptase promotes inflammatory cell accumulation and progression of established epidermal tumors

Por Sales, Katiuchia Uzzun, Friis, Stine, Abusleme, Loreto, Moutsopoulos, Niki M., Bugge, Thomas H.
Publicado no Oncogene (2014)